[go: up one dir, main page]

AU6270794A - Treatment of allergic responses using mhc-peptide complexes - Google Patents

Treatment of allergic responses using mhc-peptide complexes

Info

Publication number
AU6270794A
AU6270794A AU62707/94A AU6270794A AU6270794A AU 6270794 A AU6270794 A AU 6270794A AU 62707/94 A AU62707/94 A AU 62707/94A AU 6270794 A AU6270794 A AU 6270794A AU 6270794 A AU6270794 A AU 6270794A
Authority
AU
Australia
Prior art keywords
mhc
treatment
peptide complexes
allergic responses
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62707/94A
Other languages
English (en)
Inventor
Somesh Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anergen Inc
Original Assignee
Anergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anergen Inc filed Critical Anergen Inc
Publication of AU6270794A publication Critical patent/AU6270794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/605MHC molecules or ligands thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/62Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
AU62707/94A 1993-02-25 1994-02-24 Treatment of allergic responses using mhc-peptide complexes Abandoned AU6270794A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2381593A 1993-02-25 1993-02-25
US023815 1993-02-25
PCT/US1994/001919 WO1994018998A1 (fr) 1993-02-25 1994-02-24 Traitements de reactions allergiques au moyen de complexes peptidiques de mhc

Publications (1)

Publication Number Publication Date
AU6270794A true AU6270794A (en) 1994-09-14

Family

ID=21817341

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62707/94A Abandoned AU6270794A (en) 1993-02-25 1994-02-24 Treatment of allergic responses using mhc-peptide complexes

Country Status (2)

Country Link
AU (1) AU6270794A (fr)
WO (1) WO1994018998A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074904B2 (en) 1994-07-29 2006-07-11 Altor Bioscience Corporation MHC complexes and uses thereof
US5869270A (en) * 1996-01-31 1999-02-09 Sunol Molecular Corporation Single chain MHC complexes and uses thereof
US6232445B1 (en) 1997-10-29 2001-05-15 Sunol Molecular Corporation Soluble MHC complexes and methods of use thereof
US20240382606A1 (en) * 2021-04-20 2024-11-21 Georgia Tech Research Corporation Nanoparticles for antigen-specific cell programming and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
US5130297A (en) * 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide

Also Published As

Publication number Publication date
WO1994018998A1 (fr) 1994-09-01

Similar Documents

Publication Publication Date Title
AU3738293A (en) Compounds useful for treating allergic and inflammatory diseases
AU6916694A (en) Novel treatments for allergic diseases
AU6797094A (en) Cosmetic treatment of substrates
AU4670293A (en) Non-invasive testing
AU7419096A (en) Treatment of vegetables
AU6808194A (en) Reconstructed human antibody against human interleukin-6
AU6801694A (en) The treatment of small animals
AU618231B3 (en) Treatment of emulsions
AU1115095A (en) Treatment of cellulose
AU3538695A (en) Iodine-based germicide and method
AU1438295A (en) Method for treatment of papulo-pustules and comedones of the skin
AU6388494A (en) Skin care composition
AU6176094A (en) Eye examination apparatus and accessory therefor
AU6723294A (en) Use of simmondsine
AU6270794A (en) Treatment of allergic responses using mhc-peptide complexes
AU5340594A (en) Skin treatment
AU5737494A (en) Human thrombospondin-4
GB9211736D0 (en) Allergic treatment
AU6651794A (en) Automatisation of electro-oculographic examination
AU7565894A (en) Acupuncture treatment of common baldness
AU673961B2 (en) Methods of inhibiting the effects of amyloidogenic proteins
AU5293293A (en) Methods and compositions for treatment of allergic disease
AU8879691A (en) Treatment of dispersions
AU3053295A (en) Use of acetal-containing mixtures
AU6366994A (en) Methods for diagnosis and treatment of xscid